| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/30/2008 | CN101167889A Traditional Chinese medicine for treating syncope and rheumatoid arthritis |
| 04/30/2008 | CN101167874A Traditional Chinese medicinal composition for treating rheumatic arthritis and rheumatoid oarthritis |
| 04/30/2008 | CN101167844A Medicinal composition for anti-inflammatory pain-stopping and transforming-stasis and relieving-swelling |
| 04/30/2008 | CN101167837A Traditional Chinese medicine formula for treating osteomyelitis |
| 04/30/2008 | CN101167816A Total glycosides of ranunculus and preparation and application thereof |
| 04/30/2008 | CN101167808A Chinese medicinal herb pre-mixture for preventing swine high fever |
| 04/30/2008 | CN101167786A Process of extracting total flavone from fordia cauliflora Hemsl |
| 04/30/2008 | CN101167777A Composite medicine for treating traumatic injury and its preparing process |
| 04/30/2008 | CN101167722A Ketorolac tromethamine freezing-dried power injection and preparation method thereof |
| 04/30/2008 | CN101167708A New use of 6,7-dehydroroyleanone in pharmaceutical |
| 04/30/2008 | CN101167692A Chinese medicinal herb health-care foot bath composition |
| 04/30/2008 | CN101167505A Selenium rich rabdosia rubescens tea |
| 04/30/2008 | CN100385005C Methods for the production of multimeric proteins, and related compositions |
| 04/30/2008 | CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins |
| 04/30/2008 | CN100384880C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384879C Modified peptides as therapeutic agents |
| 04/30/2008 | CN100384873C Chimeric antagonist ANTH1 |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384846C Fused azole-pyrimidine derivatives |
| 04/30/2008 | CN100384841C Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 04/30/2008 | CN100384838C Novel benzylpiperidine compound |
| 04/30/2008 | CN100384430C Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 04/30/2008 | CN100384410C Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365155 Immunoregulator |
| 04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 04/29/2008 | US7365073 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364749 Preventing scar tissue formation on the trachea, bonchi or alveoli by administering liposomes containing povidone iodine along with an antiinflammatory agent, anesthetic, antioxidant, antibiotic, or corticoid |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | CA2370098C Human beta-trcp protein |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2309178C Topical compositions for nsai drug delivery |
| 04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
| 04/29/2008 | CA2245484C Novel urea derivatives |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/24/2008 | WO2008048914A1 Polycyclic compounds which modulate the cb2 receptor |
| 04/24/2008 | WO2008048577A1 Methods of using 4-phenylaminoquinolines as topical non-steroidal antiinflammatory compounds |
| 04/24/2008 | WO2008047983A1 Composition for preventing and treating inflammatory bowel diseases |
| 04/24/2008 | WO2008047880A1 Therapeutic agent for rheumatoid arthritis |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047819A1 Novel ester hydrolase, gene encoding the same, and use thereof |
| 04/24/2008 | WO2008047758A1 Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient |
| 04/24/2008 | WO2008047709A1 Nk1 receptor antagonist composition |
| 04/24/2008 | WO2008047680A1 External preparation for skin |
| 04/24/2008 | WO2008047109A1 Thiazole derivatives as kinase inhibitors |
| 04/24/2008 | WO2008047067A1 Treatment of inflammatory disease |
| 04/24/2008 | WO2008046798A1 Isoindol derivatives as ep4 receptor agonists |
| 04/24/2008 | WO2008046647A1 VR1 RECEPTOR LIGANDS AND µ OPIOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN |
| 04/24/2008 | WO2008046598A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/24/2008 | WO2008046573A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | WO2008046285A1 The uses of the carboxy-amido-triazole compounds and salts thereof |
| 04/24/2008 | WO2008023336A3 Matrix metalloproteinase inhibitors |
| 04/24/2008 | WO2008020206A3 Fused thiophene derivatives as mek inhibitors |
| 04/24/2008 | WO2006079099A3 Method of conjugating aminothiol containing molecules to a polymer |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096971 Treatment of Inflammatory Disorders and Pain |
| 04/24/2008 | US20080096965 (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators |
| 04/24/2008 | US20080096963 Especially bee stings; linoleic acid, oleic acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, lignoceric acid, or palmitoleic acid; also administered by injection; ointments, creams, gels, patches, powders, sprays, lotions, sticks; antiallergens, antihistamines |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096948 Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation |
| 04/24/2008 | US20080096943 Urea derivatives, for example, 1-(3,5-dimethyl-isoxazole-4-yl)-3-[4-[(4-fluorobenzyl)methylamino]-butyl]-urea; use in treating inflammatory or allergic condition such as an inflammatory or obstructive airways disease |
| 04/24/2008 | US20080096931 fewer side effects; 2-keto-oxadiazole derivatives; 7-phenyl-1-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]-heptan-1-one; treat anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders |
| 04/24/2008 | US20080096929 enzyme myeloperoxidase inhibitor; 5-Phenoxymethyl-4-(dihydrofuran-2-one-3-yl)-2,4-dihydro-[1,2,4]triazole-3-thione; treatment or prophylaxis of neuroinflammatory disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease and stroke, COPD, asthma, inflammatory bowel disease |
| 04/24/2008 | US20080096925 Analgesics for neuropathy, surgery, nervous system disorders, headaches, arthritis, psoriasis, respiratory system disorders, and gastrointestinal disorders; ethyl 4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-1-piperidinecarboxylate; |
| 04/24/2008 | US20080096919 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 04/24/2008 | US20080096902 By inhibiting prostaglandin or cyclooxygenase-2 production; indolequinazoline alkaloids rutaecarpine or evodiamine, and butylated hydroxytoluene; skin disorders: erythromelalgia, Raynaud's Disease |
| 04/24/2008 | US20080096901 Aminotriazole compounds useful as inhibitors of protein kinases |
| 04/24/2008 | US20080096897 water soluble; lower toxicity by photosensitization; anticancer; antitumor; antiinflammatory; arthritis; osteoporosis; ocular abnormal angiogenesis; multiple sclerosis, asthma, atherosclerosis |
| 04/24/2008 | US20080096893 Tablets containing 0.1 mg to 0.4 mg aminopterin in increments of 0.05 mg; uninterrupted dosage cycles as an antiinflammatory agent; nontoxic; side effect reduction |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096884 phosphodiesterase inhibitors; inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 04/24/2008 | US20080096882 PDE4 (Phosphodiesterase) inhibitors; respiratory diseases, gastrointestinal diseases, inflammation the joints, skin or eyes, cancers, or diseases of the peripheral or central nervous system |
| 04/24/2008 | US20080096861 Chemical Compounds |
| 04/24/2008 | US20080096830 9a-aza-9a-Homoerythromycin derivatives with a dibenzo[e,h]azulene subunit; asthma, adult respiratory distress syndrome; gastrointestinal, respiratory system, autoimmune, genetic, skin, rheumatic, or smooth muscular disorders; inhibitors of tumor necrosis factor, interleukins, leukotrienes, lipoxygenase |
| 04/24/2008 | US20080096827 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans For Use In The Prevention And Treatment Of Cognitive Decline And Age-Related Memory Impairments |
| 04/24/2008 | US20080095850 produces homogeneous, free flowing, attrition resistant, uniform sized granules of etoricoxib for treating pain and inflammation in patients that cannot swallow a tablet |
| 04/24/2008 | US20080095849 Peptide sustained release compositions and uses thereof |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095738 Vlp-Antigen Conjugates and Their Uses as Vaccines |
| 04/24/2008 | CA2672926A1 Bicyclic heteroaromatic compounds |
| 04/24/2008 | CA2666406A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | CA2665376A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914305A1 GSK3 polypeptides |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914232A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 04/23/2008 | EP1914223A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1913155A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 04/23/2008 | EP1913003A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES |
| 04/23/2008 | EP1912985A1 Imidazopyridine derivatives as cannabinoid receptor ligands |
| 04/23/2008 | EP1912941A1 Novel piperidine derivatives |